Privigen TW Solution for Intravenous Infusion
發證日期:2023-09-15
適應症狀:
1、作為替代療法(1)原發性免疫不全症(Primary immunodeficiency syndromes,PID)如:甲、先天性丙種免疫球蛋白缺乏症(congenital agammaglobulinemia)及丙種免疫球蛋白過低症(hypogammaglobulinemia)乙、常見變異性免疫不全症(common variable immunodeficiency)丙、嚴重複合型免疫不全症(